Hema Now: The Next Era of Paediatric Haemophilia Management

In this episode of Hema Now, Marilyn Manco-Johnson explores the evolution and future of paediatric haemophilia care. From the early adoption of prophylactic treatment to today's rapidly advancing therapeutic landscape, she reflects on the milestones that have transformed outcomes for children. The conversation also dives into ongoing challenges, including joint health, variability in treatment response, and access to care, while highlighting emerging innovations such as gene therapy and non-factor therapies that could redefine long-term management.  Timestamps:   00:00 – Introduction   00:49 - Career inspiration   04:40 - Prophylaxis turning points   09:41 - Key care advances   12:12 - Current research questions   15:00 - Joint risk factors   19:10 - Emerging therapies impact   24:24 – Recognising joint pain   26:08 - Gaps in care   29:11 - Future priorities